Freshpet (FRPT) Q3 2024 earnings summary

Executive summary

• Achieved 25th consecutive quarter of over 25% year-over-year net sales growth, with Q3 2024 net sales up 26.3% to $253.4 million, driven primarily by volume gains and strong household penetration, especially among high-value customers (HIPPOs/HIPPOHs).

• Adjusted gross margin and EBITDA margin expanded significantly, with Q3 adjusted gross margin at 46.5% and EBITDA margin at 17.2%, reflecting operational improvements and disciplined growth.

• Net income for Q3 2024 was $11.9 million, reversing a net loss in the prior year, with year-to-date net income at $28.8 million.

• Operating cash flow for Q3 was $56.1 million, with $103.9 million generated year-to-date; cash on hand at quarter-end was $274.6 million.

• Retail presence expanded with 22% more distribution points, over 1,000 new stores, and increased shelf space in retailer-owned fridges.

Financial highlights

• Q3 2024 net sales reached $253.4 million, up 26% year-over-year, driven entirely by volume growth.

• Adjusted gross margin improved to 46.5% (+630 bps), and adjusted EBITDA rose to $43.5 million (17.2% margin), up from $23.2 million (11.6%) in Q3 2023.

• Net income for Q3 was $11.9 million; year-to-date net income was $28.8 million.

• Logistics costs as a percent of net sales reached a record low of 5.6%, improving by 120 basis points year-over-year.

• SG&A expenses were $90.3 million (35.7% of sales) in Q3 2024, down 90 bps as a percentage of sales year-over-year.

Outlook and guidance

• 2024 net sales guidance raised to approximately $975 million (27% growth), with adjusted EBITDA guidance increased to at least $155 million.

• Adjusted gross margin expected to expand by 600 bps for the full year; capital expenditures guidance reduced to ~$180 million due to project timing.

• Free cash flow positive is expected in 2026, with no additional capital needs anticipated.

• Sequentially lower percentage sales growth expected in Q4 due to media spend timing, with higher media investment in the second half of 2024 to drive 2025 growth.